Sentinel BioTherapeutics
PrivateLast Round
Seed
May 29, 2025
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Sentinel BioTherapeutics is a biotechnology company that develops localized cytokine immunotherapies using encapsulated allogeneic cell-based protein producers to treat solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sentinel BioTherapeutics Comparables
Compare Sentinel BioTherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aulos Bioscience | 75% | |
| Imunon Inc | 74% | |
| Xilio Therapeutics | 72% | |
Sentinel BioTherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 29, 2025 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 61% MoM, reaching 1K.
- Jul 27, 2026
Monthly visitors increased 1320% MoM, from 45 to 639.
Sentinel BioTherapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Sentinel BioTherapeutics's valuation, stock price, and market status.